You, Shuhui
120  Ergebnisse:
Personensuche X
?
4

Real-world data of triplet combination of pyrotinib, trastu..:

You, Shuhui ; Sang, Die ; Xu, Fei...
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. , 2023
 
?
6

ER status conversion and subsequent treatment: an assessmen..:

You, Shuhui ; Xie, Yizhao ; Ji, Mengjing...
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. , 2023
 
?
10

Real-world data of triplet combination of pyrotinib, trastu..:

You, Shuhui ; Sang, Die ; Xu, Fei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748899/.  , 2023
 
?
11

Clinicopathological characteristics, evolution, treatment p..:

You, Shuhui ; Gong, Chengcheng ; Li, Yi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595148/.  , 2023
 
?
12

Comparing pyrotinib with trastuzumab and pertuzumab with tr..:

You, Shuhui ; Xie, Yizhao ; Sang, Die...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10750407/.  , 2023
 
?
13

Pretreatment (18)F‐FDG uptake heterogeneity may predict tre..:

Ma, Guang ; You, Shuhui ; Xie, Yizhao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510219/.  , 2023
 
?
14

Chemotherapy Shows a Better Efficacy Than Endocrine Therapy..:

Xie, Yizhao ; Du, Xinyue ; Zhao, Yannan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323202/.  , 2022
 
?
15

Development and validation of nomograms to intraoperatively..:

Zhao, Fei ; Lu, Rong-Xin ; Liu, Jin-Yuan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786479/.  , 2021
 
1-15